Paper I — 2013 September (Supplementary) (2010 Scheme) — Q12

Paper I

2013 September (Supplementary) (2010 Scheme) · 40 marks · 120 min

Question

List two advantages of low molecular weight heparin over standard heparin

Q121 marksShort Answers★✓

Answer

• More predictable anticoagulant response — better bioavailability, allows fixed/weight-based dosing without routine coagulation monitoring
• Longer duration of action — permits once/twice-daily subcutaneous dosing (vs. continuous IV infusion for standard heparin) and lower risk of heparin-induced thrombocytopenia and osteoporosis

Related Concepts

1. 1Drugs for Disorders of Calcium Balance

Other Years Asked

1. 1Classify bisphosphonates. Explain in detail on the mechanism of action, uses and adverse effects of bisphosphonates2024 March (Supplementary) (2019 Scheme)Short Essay · 8 marks
2. 2A 60-year-old lady presents with back pain and in the legs. She also complains of a recent fracture in the right wrist joint. After investigation, the physician made a diagnosis of Osteoporosis. She was prescribed Alendronate. Explain the mechanism of action and adverse effects of Alendronate. (4+2)2025 March (Supplementary (SAY)) (2019 Scheme)Short Essay · 6 marks
3. 3A 30 years old pregnant woman attended to hospital with a complaint of sudden onset of swelling of right leg and tenderness over calf. Venous Doppler of right leg suggestive of presence of a large thrombus in leg veins.2021 December (Supplementary) (2010 Scheme)Essay · 6 marks
4. 4Bisphosphonates2015 February (2010 Scheme)Short Note · 3 marks
5. 5Bisphosphonates2014 September (Supplementary) (2010 Scheme)Short Note · 3 marks
6. 6Bisphosphonates2017 August (Supplementary) (2010 Scheme)Short Note · 3 marks
7. 7Mention two important uses and adverse effects of glucocorticoids.2017 February (2010 Scheme)Short Answer · 1 mark
8. 8Treatment of Paget’s disease2016 February (2010 Scheme)Short Answer · 1 mark
9. 9Bisphosphonates2014 March (2010 Scheme)Short Answer · 1 mark
10. 10Treatment of osteoporosis2017 February (2010 Scheme)Short Answer · 1 mark
11. 11Osteoporosis.2013 September (Supplementary) (2010 Scheme)Short Answer · 1 mark
12. 12Alendronate in osteoporosis management2022 October (Supplementary) (2010 Scheme)Short Answer · 1 mark
13. 13Bisphosphonates.2025 March (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
14. 14Bisphosphonates2025 August (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
15. 15Bisphosphonates2021 February (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
16. 16Bisphosphonates used in postmenopausal Osteoporosis.2022 May (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
17. 17Drugs used for osteoporosis2024 June (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
18. 18Vitamin D preparations2024 June (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
19. 19Drugs for treating Osteoporosis.2023 January (Supplementary) (2019 Scheme)Short Answer · 0.2 marks